NORDIKA Pharmaceutical of Brazil will undertake the design and engineering associated with the plant and machinery layout. Upgrading the site will begin immediately and will involve an investment in excess of US $50m. The target is to have the fully digitalised plant commissioned and operating by 2023.
Phase 1 will be to lease circa 20,000 sq meters to enable the production of 5 million Lithium Sulfur (Li-S) cells per annum with the option to extend and double the estate and cell capacity.
This will create hundreds of mainly high-skilled jobs over the next ten years with OXIS having access to the expertise and innovation of students at the reputable universities of Juiz de Fora. Reflecting its collaborative success with universities in the UK